ABT holders · CITADEL ADVISORS LLC 13F · ABT stock
CITADEL ADVISORS LLC Abbott Laboratories (ABT) 13F holding
CITADEL ADVISORS LLC reported 1,567,900 ABT shares valued at $160.98B as of 2026-03-31 (COM), Call. Cached 13F row, not a live tape.
| Report | Shares | Value | Class |
|---|---|---|---|
| 2026-03-31 | 1,567,900 | $160.98B | Call |
| 2026-03-31 | 1,245,954 | $127.92B | COM |
| 2026-03-31 | 669,892 | $68.78B | COM |
| 2026-03-31 | 329,900 | $33.87B | Put |
| 2026-03-31 | 3,900 | $400.4M | Call |
| 2026-03-31 | 2,700 | $277.2M | Put |
| 2025-12-31 | 2,458,000 | $307.96B | Call |
| 2025-12-31 | 2,080,034 | $260.61B | COM |
| 2025-12-31 | 649,400 | $81.36B | Put |
| 2025-09-30 | 1,876,200 | $251.30B | Call |
| 2025-09-30 | 872,400 | $116.85B | Put |
| 2025-09-30 | 585,801 | $78.46B | COM |
| 2025-09-30 | 5,800 | $776.9M | Put |
| 2025-06-30 | 2,120,700 | $288.44B | Call |
| 2025-06-30 | 940,700 | $127.94B | Put |
Not investment advice. Cached 13F row, not EDGAR XML.